Atrandi Biosciences | Droplet Genomics

📍 Vilnius, Lithuania🗓 Founded 2016👥 52 employees💰 Last funded Mar 2022
Biotechnology Research🌐 atrandi.com
Website LinkedIn
Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for groundbreaking high-throughput research by integrating different technologies.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Lithuania
1
Frequently asked questions
Who invested in Atrandi Biosciences | Droplet Genomics?
Atrandi Biosciences | Droplet Genomics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Atrandi Biosciences | Droplet Genomics last raise funding?
The most recent investment in Atrandi Biosciences | Droplet Genomics recorded on gritt.io was in March 2022.
When was Atrandi Biosciences | Droplet Genomics founded?
Atrandi Biosciences | Droplet Genomics was founded in 2016.
What industry is Atrandi Biosciences | Droplet Genomics in?
Atrandi Biosciences | Droplet Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Atrandi Biosciences | Droplet Genomics based?
Atrandi Biosciences | Droplet Genomics is headquartered in Vilnius, Lithuania.